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Objective:A significant increase in the frequency of inferior vena cava (IVC) filter placement at our large community-based
academic health center led us to evaluate changes in indications, devices, and providers over the past decade.
Methods: A single-center retrospective review of all filter placements was performed comparing 76 patients in 1995 with
470 patients in 2005. Demographic data, provider data, filter type, and indications for placement were tabulated.
Complications, follow-up evaluation, filter removal, and patient outcomes were examined.
Results:There was a greater than sixfold increase in the number of filters placed in 2005 vs 1995. There were no significant
differences in patient demographics or the extent of venous thromboembolic (VTE) disease during this period except for
an increase in median age. Filter placement by interventional radiologists remained approximately 50% of the total
whereas placement by vascular/trauma surgeons increased to 24% and placement by cardiologists decreased to 29% (P <
.001). In 2005, a smaller percentage of filters were placed for absolute indications, while filter placements for relative and
prophylactic indications increased over the same time period, especially among cardiologists (P  .02). Potentially
retrievable filters are increasingly being used for prophylaxis; however, only 2.4% were retrieved. An increasing number
of filters were placed in patients with only infrapopliteal deep venous thrombosis (P  .07). A shift was seen to lower
profile and removable filter types. Long-term patient follow-up showed little change in disease progression or in
morbidity and mortality of filter insertion.
Conclusions: Technological and practice pattern changes have led to an increase in filters inserted by vascular and trauma
surgeons in the operating room and intensive care units. Increased diagnosis of VTE disease and newer low profile
delivery systems in patients may also have contributed to the significant increase in filter placement. A shift in indications
for placement from absolute toward relative indications and prophylaxis is evident over time and across providers,
indicating the need for consensus development of appropriate criteria. ( J Vasc Surg 2008;47:157-65.)The incidence of venous thromboembolism (VTE) has
remained relatively constant since about 1980, with an
average annual incidence of more than one case per 1000
person years.1 However, the use of inferior vena cava (IVC)
filters has increased markedly over the last two decades.2,3
This may be due to some combination of improved filter
technology, liberalization of indications for insertion, an
increasing number of providers available for IVC filter
placement, and an increased appreciation of the morbid
potential of VTE. The changing trends in indications and
providers over the last decade caused us to evaluate the
experience with IVC filter placement at William Beaumont
Hospital, a community-based Academic Health Center
located in Royal Oak, Michigan.
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After obtaining approval by the human investigation
committee of the hospital, a single-center retrospective
study was performed. All IVC filters placed during calendar
years 1995 and 2005 at our 1067 bed hospital in South-
eastern Michigan were reviewed, comparing a cohort of 76
patients in 1995 with a cohort of 470 patients in 2005.
Medical charts and computerized records for each patient
were reviewed by physicians. Standard demographic data,
provider discipline, filter type, indications for placement,
follow-up studies performed, and patient outcomes were
collected. The indications for IVC filter placement were
grouped as absolute, relative or prophylactic based upon
previously published recommendations.4-9 Patients with
documented VTE disease were categorized as having either
absolute or relative indications, while patients at high risk
but without any documented VTE disease were assigned to
the prophylactic category (Table I). Patients having more
than one indication were categorized by the most clinically
relevant indication. If a filter was placed for a recurrent VTE
event despite anticoagulation, the adequacy of anticoagu-
lation was confirmed by reviewing the patient’s prothrom-
bin time, international normalized ratio, and/or activated
clotting time values. Anticoagulation was in the majority of
cases established with intravenous unfractionated heparin
and/or warfarin; a small number of patients in the 2005
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ular weight heparin.
Computerized electronic records or paper patient
charts were reviewed for recurrent VTE disease as of July
2007. Follow-up studies included lower-extremity venous
duplex exams, chest computed tomography (CT) scans
performed with a pulmonary embolism (PE) protocol and
ventilation-perfusion scans. A follow-up duplex scan was
considered positive for worsening deep venous thrombosis
(DVT) if it displayed clot progression beyond the baseline
study obtained prior to filter placement. To be considered
negative for progression of DVT disease, a duplex scan
performed at least 30 days after filter placement must show
no progression from baseline. Occurrence of a new PE was
documented by the presence of new pulmonary artery
filling defects on chest CT using high resolution PE proto-
col. Such studies were obtained based solely on clinical
suspicion. Ventilation perfusion scans were used less fre-
quently in 2005; only one patient had a recurrent PE
diagnosed with this modality. All reported deaths were
reviewed for cause of death and time from placement of
filter.
In 1995, IVC filters were placed by cardiologists and
radiologists in their angiography suites; at that time, sur-
geons at our institution did not place filters. In 2005, filters
were being placed by cardiologists and radiologists in an-
giography suites and by vascular and critical care/trauma
surgeons, either in the operating room with angiographic
capability or in the intensive care with bedside portable
Table I. Indications for IVC filter placement
Absolute indications for IVC filter placement in VTE disease:
1. Contraindication to anticoagulation:
a. Bleeding complication of anticoagulation or recent history of
gastrointestinal or intracranial bleeding, significant hemato
b. Central nervous system infarct, neoplasm, trauma, or recent/
c. Significant thrombocytopenia (50,000/mm3)
d. Major extremity/torso trauma precluding anticoagulation, su
2. Failure of anticoagulation:
a. Recurrent pulmonary embolism despite anticoagulation
b. Progression of ileo femoral clot despite anticoagulation
3. Heparin associated thrombocytopenia-thrombosis syndrome
Relative indications for IVC filter placement in VTE disease:
1. Poor candidate for anticoagulation:
a. Old age with risk of falls/ ataxia/ history of seizures
b. Poor compliance with anticoagulation medication by patient
c. Neoplasm with potential bleeding risk such as GI, GU cance
d. Patient in a periprocedural period having risk of bleeding fro
2. Massive PE in which recurrent emboli may prove fatal
3. Ileo femoral deep venous thrombus with a free floating tip
4. During or after surgical embolectomy
Prophylactic indications for IVC filter placement with no active VT
1. Major trauma:
a. Multiple long-bone or complex pelvic fractures
b. Spinal cord injury with immobilization from para- or quadrip
2. Morbidly obese and/or immobile patients
3. High risk patients undergoing:
a. Spine surgery
b. Bariatric surgery
IVC, Inferior vena cava; VTE, venous thromboembolic; CNS, central nervofluoroscopy units. In all cases, percutaneous technique wasused to gain venous access and venography performed to
delineate the venous anatomy and rule out caval thrombo-
sis. Post deployment venography was not always per-
formed; however, in most cases, spot fluoroscopic images
were taken to confirm filter alignment and deployment.
Statistical analysis. All categorical variables are shown
as count and percent frequencies, and were examined using
Pearson 2 test or Fisher exact test as appropriate. Age is
shown as median with 25th to 75th percentile ranges and
was examined using a Wilcoxon rank test as age was not
normally distributed. In all instances P  .05 was consid-
ered significant. SAS version 9.1.3 (Cary, NC) was used for
all analyses.
RESULTS
Patient demographics. The absolute number of IVC
filters placed increased dramatically from 76 in 1995 to 470
filters in 2005, representing a greater than sixfold increase.
During this time, hospital admissions increased 33%
(43,770 to 58,106) and orthopedic admissions increased
from 8.4% of total admissions to 10.9% (3666 to 6329).
Trauma admissions during this time period increased 19%
from 1371 to 1624. Median (25th to 75th percentile range)
patient age was 68 years (59 to 75 years) in 1995 and 74
years (58 to 83 years) in 2005 (P .022); in 1995, 47% of
patients were male vs 46% in 2005 (P .860). The median
age of patients of all providers increased from 1995 to 2005
(P .02). Patients with filters placed by critical-care/
trauma surgeons in 2005 were significantly younger than
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years (62 to 83 years) for other providers, reflecting the
typically younger trauma patient population (P  .0001).
Associated complications and comorbidities for patient
groups were collected and analyzed using ICD-M codes
which summarize events recognized during the hospital
admission when the IVC filter was placed. Comorbidities
are listed in Table II in the online appendix to this publi-
cation, which shows respiratory, musculo-skeletal, blood
and digestive system comorbidities increased significantly
in the 2005 group compared with 1995 patients.
Venous thromboembolic disease. The type of VTE
disease in patients undergoing IVC filter placement was
comparable in both study periods (P  .23). The majority
of filters were placed in patients with documented venous
thromboembolic disease; however, increased prophylactic
placement of filters in patients at risk for but with no
documented VTE disease is seen (Fig 1).
Provider distribution. Cardiologists and interven-
tional radiologists placed an equal number of IVC filters in
1995; no filters were placed by surgeons during this period.
A decreasing percentage of filters were placed by cardiolo-
gists in 2005 vs 1995, while trauma and vascular surgeons
accounted for 24% of the total number of filters placed in
2005 (P  .001) (Fig 2).
Indications for placement. A smaller percentage of
filters were placed for absolute indications in 2005 vs 1995,
while filter placements for relative and prophylactic indica-
tions increased over the same time period (P .12) (Fig 3).
The majority of the filters placed by cardiologists in
1995 were for absolute indications, while in 2005 the
majority of filters placed by cardiologists were for relative
and prophylactic indications (P .020) (Fig 4). The num-
ber of filters placed for relative indications by interventional
radiologists increased from 1995 to 2005; however, the
majority of filters placed by these providers remain for
absolute indications (P .350) (Fig 4). A trend change
cannot be analyzed for surgeons since they did not place
filters in 1995. When all providers are considered, cardiol-
ogists place the highest percentage of filters for relative
Fig 1. Venous thromboembolic disease at the time IVC filter
placement in 1995 (n  76) and 2005 (n  470). No significant
difference was seen between the two time periods (P  .23).indications and the lowest percentage for absolute indica-tions. The largest percentage of filters placed for prophy-
lactic indications are placed by trauma surgeons (Fig 5).
The percentage of filters placed for absolute indications
decreased from 67% in 1995 to 57% in 2005 but this
decrease was not significant (P  .09). There was a signif-
icant increase (3.9% in 1995 to 13.5% in 2005, P .05) in
the number of filters inserted to protect the neurosurgical
Fig 2. Distribution of providers for IVC filter placement in 1995
and 2005.
Fig 3. Indications for IVC filter placement in 1995 and 2005.
Differences between the two time periods were not statistically
significant (P  .12). N for each group is indicated at the base of
each bar.
Fig 4. Indications for IVC filter placement by cardiologists and
radiologists in 1995 and 2005. Statistically significant differences
were seen between the two time periods for cardiologists (P .02)
but not for radiologists (P .35). N for each group is indicated at
the base of each bar.patient population in whom anticoagulation was judged
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ber of filters placed for recurrent PE despite anticoagulation
(31.4% in 1995 to 15% in 2005 P.0049). The frequency
of other absolute indications for filter placement as listed in
Table I remain unchanged and are available in detail in
Table III in the online appendix for this publication.
The percentage of filters inserted for relative indications
was similar in 1995 and in 2005 (30% vs 35%, P  .39).
There was a decrease in the percentage of filters used solely
for peri-operative protection (47.8% in 1995 to 17.5% in
2005, P .0021), with concomitant adaptation of antico-
agulation protocols. However, there was a significant in-
crease (17.4% in 1995 to 54.8% in 2005, P .0008) in the
number of filters placed in patients considered to be poor
candidates for anticoagulation based on old age and/ or
risk of falls. This trend is present across all providers,
although the increase reaches statistical significance only for
filter placement by radiologists (0% in 1995 to 59% in 2005,
P .0002). The frequency of other relative indications for
filter placement as listed in Table I remain unchanged and
are available in detail in Table IV in the online appendix for
this publication.
The number of filters inserted for prophylactic indica-
tions rose from 2.6% in 1995 to 7.9% in 2005 (P .10).
Fully 58.6% of prophylactic filters in 2005 were inserted in
trauma patients withmultiple long bone/pelvic fractures or
spinal cord injury and 32.4% of prophylactic filters were in
bariatric surgery patients. One patient had an IVC filter
inserted with no apparent indication for anticoagulation in
the medical records.
Patients with infrapopliteal lower extremity DVT
only. For patients with lower extremity DVT confined to
infrapopliteal veins only, the placement of IVC filters in-
creased from 2.6% (2/76) in 1995 to 8.5% (40/470) in
2005 (P .07). The two filters placed in 1995 for infrap-
opliteal disease were for absolute indications, but in 2005
45% (18/40) of filters placed in patients with infrapopliteal
DVTwere placed for the relative indication of the patient as
a poor candidate for anticoagulation due to old age/risk of
falls (13/40, 33%), neoplasm with potential for bleeding
(2/40, 5%) or proximity of other procedures (3/40, 8%).
Fig 5. Distribution of indications for IVC filter placement among
all providers during 2005.Table V in the online appendix to this publication shows indetail the number of filters placed in such patients for
absolute and relative indications by provider type. Fol-
low-up imaging and outcomes in this group of patients is
reported below.
Filter type and the retrieval of filters. The types of
IVC filters placed in 1995 and 2005 are shown in Table VI.
The majority of filters placed in 1995 were either the
titanium or stainless steel percutaneous Greenfield type. In
2005, a greater variety of filters were placed, with a shift to
the more recently available low profile and potentially
retrievable filters (7F). The use of the 12F Greenfield
filter (Boston Scientific, Natick, Mass) decreased from 83%
of all filters placed in 1995 to 8% in 2005. Retrievable filters
were increasingly used (n 167) but only four (2.4%) were
retrieved. The most common indication at the time of
placement for retrievable filters was an absolute contraindi-
cation to anticoagulation (34.1%); this is followed by pa-
tients who are poor candidates for anticoagulation due to
old age and/or risk of falls (12%) (Table VII). The provid-
ers for placement and retrieval of these filters are shown in
Table VIII. One additional patient underwent an unsuc-
cessful attempt at retrieval 4 months after placement.
Follow-up imaging and patient outcomes. Medical
records were reviewed to identify patient outcomes follow-
ing filter placement. Table IX shows the follow-up imaging
and outcomes of the 2005 year patients; it also highlights
the percentage of these patients who received post-filter
anticoagulation. The majority of these patients were anti-
coagulated with intravenous unfractionated heparin and
oral warfarin. Low molecular weight heparin (Lovenox)
using DVT treatment dosage was prescribed in 1.7% (8/
470) of these patients. Interestingly, 14 of 91 (15%) pa-
tients considered poor candidates for anticoagulation at the
time of filter placement due to age/risk of falls continued to
receive anticoagulation post-filter placement. A detailed
breakdown of follow-up data by subindication for filter
placement as listed in Table I is available in Table IX, a in
the online appendix for this publication. Follow-up duplex
imaging was performed in patients with clinical suspicion of
PE or lower extremity clot progression. Lower extremity
ultrasound was performed on 28% of these patients (131/
470); 49% (64/131) showed clot progression. Similarly,
follow-up chest CT scan with PE protocol was performed
in 12% (55/470) of patients; 12% (7/55) of these showed
new pulmonary embolism. Follow-up duplex imaging in
the lower extremity infrapopliteal DVT-only group was
performed on 25% (10/40) of these patients; 60% (6/10)
revealed DVT clot progression.
Complications. The complications observed in 1995
patient group included a neck hematoma (1/76, 1.3%),
respiratory insufficiency within 24 hours of filter placement
(2/76, 2.6%), clot progression on follow-up duplex scan
(2/76, 2.6%), death from cardio-pulmonary failure,
and/or sepsis within a week of filter placement (3/76,
3.9%). The complications observed in the 2005 patient
group included groin hematoma (2/470, 0.4%), phlegma-
sia cerulea dolens at 10 days (1/470, 0.2%) and 3 weeks
(1/470, 0.2%) following filer placement, and IVC throm-
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not possible to determine if these complications result from
Table VI. Type of IVC filters placed in 1995 and 2005, in
Filter type 1995 N  76
Greenfield (titanium/stainless steel) (12F) 63 (83%)
Vena Tech (LGM/LP) (12F/7F) 10 (13%)
Gunther Tulip (9F – retrievable) 0
Trap-Ease (6F) 0
Opt-Ease (6F – retrievable) 0
Simon-Nitinol (9F) 2 (3%)
Bird’s Nest (14F) 1 (1%)
IVC, Inferior vena cava.
Table VII. Subindications for filter placement at the
time of retrievable filter insertion
Filter indications at the time of retrievable
filter placement
Number of
retrievable
filters placed
Absolute - bleeding complication 57 (34.1%)
Absolute – CNS infarct/tumor/trauma
surgery
16 (9.6%)
Absolute – thrombocytopenia 3 (1.8%)
Absolute – trauma – solid organ injury 5 (3.0%)
Absolute – recurrent PE with
anticoagulation
12 (7.2%)
Absolute – progression of DVT with
anticoagulation
3 (1.8%)
Absolute – heparin associated
thrombocytopenia
0 (0%)
Relative – poor candidate – old age/falls 20 (12.0%)
Relative – poor compliance 4 (2.4%)
Relative – neoplasm with potential to bleed 2 (1.2%)
Relative – periprocedural period 13 (7.8%)
Relative – massive PE 5 (3.0%)
Relative – free-floating ileo femoral DVT tip 3 (1.8%)
Relative – during/after surgical
embolectomy
0 (0%)
Prophylactic – long bone/pelvic fractures 9 (5.4%)
Prophylactic – spinal cord injury 8 (4.8%)
Prophylactic – morbidly obese/ immobile
patient
4 (2.4%)
Prophylactic – prior to spine surgery 1 (0.6%)
Prophylactic – prior to bariatric surgery 2 (1.2%)
CNS, Central nervous system; PE, pulmonary embolism;DVT, deep venous
thrombosis.
Table VIII. Providers for retrievable IVC filters
Provider
Number of
retrievable
filters
inserted
Number of
retrievable
filters
retrieved
Time interval
between placement
and retrieval
Cardiologist 2 (1.3%) 1 1 mo
Radiologist 98 (59.0%) 1 1 mo
Vascular surgeon 14 (8.4%) 1 3 wk
Trauma surgeon 52 (31.3%) 1 1 mo
IVC, Inferior vena cava.filter insertion or represent progression of the originaldisease state. The features of the hospital course for the
2005 year patients who developed caval thrombosis or
phlegmasia cerulea dolens are shown in Table X in the
online appendix to this publication.
Of the 2005 year patients, 81 of 470 (17.2%) died in
the 2-year follow-up period (Table XI), and 89% (72/81)
of these patients died within 6 months of filter placement.
Six deaths occurred within 24 hours of filter placement in
2005. None of these patient deaths were a direct result of
technical complications of filter placement. However, one
patient died from aspiration pneumonia (1/470, 0.2%) and
one from PE (1/470, 0.2%) within 24 hours of filter
placement, which may have contributed to their deaths.
DISCUSSION
Anticoagulation remains the standard approach for pa-
tients with VTE disease. The American College of Chest
Physicians (ACCP) consensus conference recommends the
utilization of IVC filters in patients with a contraindication
to (or a complication of) anticoagulation, heparin-induced
thrombocytopenia, and in patients with recurrent VTE
disease despite anticoagulation.5 Previous randomized
controlled trials have demonstrated the efficacy of prophy-
lactic placement of IVC filters to reduce the short-term risk
of pulmonary embolism in patients with documented VTE
disease treated with anticoagulation albeit with an in-
creased long-term incidence of recurrent DVT and without
any long-term reduction in mortality.10
The present study demonstrates significant changes in
the placement of IVC filters at a high-volume center,
including a reduction in the proportion of filters being
placed for absolute indications from 67.1% in 1995 to
56.8% in 2005, suggesting that a greater percentage of IVC
filters are being placed for relative and prophylactic indica-
tions.
We observed an increase in the placement of filters for
progression of DVT in spite of anticoagulation, which did
not reach statistical significance; this may relate to im-
proved technology and ease of venous duplex scanning
now available compared with 1995. Our study also dem-
onstrated a significant increase in placement of filters in
patients with VTE disease and central nervous system
(CNS) infarct, tumor, or planned CNS surgery. There is
little long-term data on the outcome of filters in this
ing number of retrievable filters retrieved
2005 N  470 Number of retrievable filters retrieved
38 (8%)
116 (25%)
107 (23%) 2
141 (30%)
60 (13%) 2
2 (0.4%)
0cludparticular patient group; however, in the present study
ted to
mbosi
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associated with either CNS infarct, tumors, or planned
CNS surgery. When clinically indicated, lower extremity
duplex ultrasound follow-up in 28% (10/36) of this cohort
showed 9/10 (90%) with DVT clot progression. Similarly,
follow-up chest CT scan in 8% (3/36) of these patients
showed recurrent PE in the absence of anticoagulation in
1/3 (33%). Filter placement for the indication of recurrent
PE despite anticoagulation showed a statistically significant
decrease. This decrease may have been in part due to the
fact that in 1995 the diagnosis of PE was based largely on
clinical suspicion with a “suggestive” ventilation-perfusion
Table IX. Post-filter anticoagulation and follow-up imagi
Indication for
filter placement N
Post-filter
anticoagulation
Follow-up dup
No
Yes
prog
Absolute 267 49 (18%) 187 (70%) 35 (
Relative 166 58 (35%) 121 (73%) 28 (
Prophylactic 37 2 (5.4%) 31 (84%) 4 (
Total 470 109 (23%) 339 (72%) 67 (
Lower extremity
infrapopliteal
DVT only
40 5 (12.5%) 30 (75%) 4 (
VTE, Venous thromboembolic; DVT, deep venous thrombosis, CT, compu
Table X. Features of patients complicated by caval thromb
in 2005
Indication for filter Provider
Time from
filter insertion a
Pt 1 Relative - poor compliance
with anticoagulation
Radiologist 2 wk
Pt 2 Relative - colonic
neoplasm with potential
to bleed on
anticoagulation
Cardiologist 2 wk
Pt 3 Absolute -
contraindication to
anticoagulation due to
hemorrhagic pericardial
effusion
Cardiologist 3 wk
Pt 4 Absolute - recurrent PE
despite anticoagulation
Radiologist 1 y
Pt 5 Absolute – liver laceration
as contraindication to
anticoagulation for
PEDVT
Trauma
surgeon
2 wk
Pt 6 Absolute - recurrent PE
despite anticoagulation
Cardiologist 3 wk
Pt 7 Absolute - recurrent PE
despite anticoagulation
Radiologist 10 d
IVC, Inferior vena cava; PE, pulmonary embolism; DVT, deep venous throscan, whereas the diagnosis in 2005 was more objectivelybased on the presence of filling defects seen on high reso-
lution helical CT scans of the chest. Further study is war-
ranted into the safety, efficacy, and cost-effectiveness of
IVC filter placement in this cohort.
Another group for which an increased incidence of IVC
filter placement was noted was in elderly patients consid-
ered “poor candidates” for anticoagulation owing to co-
morbidities or perceived risk of falls. Filter placement for
this indication has increased from 4/76 (5.3%) filters in
1995 to 91/470 (19.4%) filters in 2005. Elderly patients
are known to be at increased for VTE disease with a higher
incidence of recurrence.11,12 Moreover, the risks of antico-
r VTE disease in 2005 patient group
ltrasound Follow-up chest CT
Yes – clot
progression No Yes – no new PE Yes – new PE
45 (17%) 231 (87%) 31 (12%) 5 (1.9%)
17 (10%) 149 (90%) 15 (9%) 2 (1.2%)
2 (5.4%) 35 (95%) 2 (5.4%) 0
64 (14%) 415 (88%) 48 (10%) 7 (2%)
6 (15%) 35 (88%) 5 (12.5%) 0
mography; PE, pulmonary embolism.
or phlegmasia cerulea dolens after IVC filter placement
st-filter
oagulation Patient outcome
Management of
complication
No Caval thrombosis and PE Placement of second
filter above the first
by radiologist
No Caval thrombosis IVC thrombectomy by
radiologist
No Caval thrombosis Placement of suprarenal
filter above the first
by vascular surgeon
No Caval Thrombosis and PE IVC/iliac vein
thrombectomy then
stent placement by
cardiologist
No Caval thrombosis IVC Thrombectomy by
radiologist
Yes Phlegmasia cerulea dolens
and venous gangrene of
lower extremity
Patient made hospice
and died of sepsis/
metastatic cancer
Yes Phlegmasia cerulea dolens
and venous gangrene of
lower extremity
Patient died of
sepsis/stroke.
s.ng fo
lex u
– no
ression
13%)
17%)
11%)
14%)
10%)osis
Po
nti-cagulation, particularly intracranial hemorrhage with rela-
vascu
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elderly patient.13-15 As the population ages, the incidence
of VTE disease and the incidence of IVC filter placement
are likely to increase in parallel suggesting a clear need for
efficacy and outcome studies in this high risk population.
Malignancy is an independent risk factor for VTE.1,16
IVC filter placement appears to be effective in preventing
PE, but there is limited survival benefit in this particular
patient population.17 Analysis in this study on cause of
death within 2 years of filter placement showed 28% (23/
81) of patients who died, died from metastatic cancer, all
but one within 6 months of filter placement. Ambulatory
status at time of placement is a significant predictor of
longer survival,18 possibly allowing identification of a sub-
set of patients with malignancy who will truly benefit from
IVC filter placement.
Rutherford argues that there has been an increased use
of potentially retrievable IVC filters for prophylactic indi-
cations.19 Retrievable IVC filters were not designed for
long-term placement and studies are not yet available on
their long-term safety. Even low complication rates when
multiplied over the lifetime of a young patient could be-
come important and must enter into the decision to place a
prophylactic retrievable IVC filter.6 Giannoudis et al re-
cently reviewed all available studies of IVC filter efficacy in
trauma patients and concluded that despite a low incidence
of PE in trauma patients, this complication has remained a
significant cause of death, and that filters appear to be both
safe and effective in reducing this complication.20 A survey
in 1997 of trauma surgeons found that the potential re-
movability of filters would significantly increase prophylac-
tic filter placement in high-risk patients from 29% to 53%.21
Reported retrieval rates vary from 34% to 84%.22-26 In the
present study, trauma surgeons did not place any IVC filters
in 1995, but were responsible for 11.3% of filters in trauma
and surgical ICU patients (all of which were retrievable
types) by 2005. Interestingly, only 2.4% of potentially
retrievable filters were removed in this study. The majority
of potentially retrievable filters that were not recovered
were placed by radiologists at the request of medical pro-
viders and the poor rate of retrieval most likely represents
inadequate follow-up by the original provider. The second
largest group of potentially retrievable filters was placed in
trauma patients, where the potential retrieval of the filter is
Table XI. Time line and cause of death over 2-year follow
PE Aspiration pneumonia Cardio- respiratory
 24 h 1 1 0
 1 wk 1 1 2
 1 mo 1 1 5
 6 mo 0 1 3
 1 y 0 1 1
 2 y 0 0 0
Total 3 5 11
PE, Pulmonary embolism; MOSF, multi-organ system failure; CVA, cerebrodesirable but may not be possible during the recommendedperiod for retrieval due to the severity of the original
injuries. In such trauma cases, where there is no reasonable
expectation of filter retrieval, prudence would suggest the
use of a filter type for which long-term (permanent) place-
ment has been studied and is accepted. Similar consider-
ations influence the placement of filters in other young age
populations such as bariatric surgery patients receiving
preoperative prophylactic filters, or pregnant women with
DVT. The indications for the placement of prophylactic
filters need to be critically evaluated and protocols should
be developed to ensure proper follow-up and timely re-
moval of filters.
Despite relative constancy in the incidence of VTE, the
absolute number of IVC filter placements increased sixfold
over 10 years at our large (1067 bed) community-based
academic health center. This occurred despite the fact that
total hospital admissions increased by only 33% during this
period. A statistically significant increase in filter placement
was observed from 76 of 43,770 total hospital admissions
in 1995 (0.17%) to 470 of 58,106 admissions in 2005
(0.81%) (P  .0001). Demographic factors that may have
contributed to increased placement include designation as a
level I trauma center in 1998 and the expansion of ortho-
pedic surgical services with an overall doubling of total joint
replacement and spine procedures. Major trauma, total
joint replacement, and spine surgery procedures are well
documented risk factors for postoperative VTE.1 Orthope-
dic admissions increased from 3666 of 43,770 in 1995
(8.4%) to 6329 of 58,106 in 2005 (10.9%). This 2% in-
crease in orthopedic admissions does not account for the
greater than fourfold increase in filter placements as a
percentage of total admissions (P .0001). Similarly, while
overall trauma admissions increased from 1371 of 43,770
in 1995 to 1624 of 58,106 in 2005, trauma admissions
decreased as a percentage of the total from 3.1% to 2.8%
over this past decade. Therefore, trauma admissions do not
fully explain the increased prevalence of filter placement. In
addition to demographic and procedural trends, an in-
creased recognition of the prevalence, natural history, and
clinical consequences of VTE disease over the past decade
may also have favored more frequent filter placement.
Improved imaging capabilities likely increased detection of
VTE disease and improvements in filter design including
in the 2005 patients
e MOSF/ sepsis Metastatic cancer CVA/ ICH Total
2 2 0 6
6 5 2 17
12 6 3 28
7 9 1 21
3 0 1 6
2 1 0 3
32 23 7 81
lar accident, ICH, intracranial hemorrhage.-up
failurlower profile delivery systems have facilitated placement by
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therapeutic index.
Proprietary filter design also varied considerably over
this study, reflecting new lower profile devices and the
desire of clinicians to gain experience with devices. In latter
years, the use of potentially retrievable devices has clearly
increased. This study did not attempt to address differences
in safety and efficacy among IVC filter devices.
Nevertheless, the aforementioned factors do not ac-
count for the provider shifts observed during the 10-year
period of this study. These appear to be related to both
technologic advances and practice pattern changes. Prior to
1995, IVC filters were placed almost exclusively by sur-
geons because they required a surgical exposure of the
internal jugular or common femoral vein. Design modifi-
cations of the prototypical stainless steel Greenfield filter
facilitating percutaneous placement led to a practice change
whereby surgeons initially delegated this procedure to in-
terventional radiologists and subsequently to cardiologists.
The evolution of vascular surgical practice, in particular the
rapid assimilation of endovascular skills, resulted in a shift
back to vascular surgeons and trauma surgeons for filter
placement first in the operating room and subsequently in
the intensive care unit. Surgeons now place 24% of all IVC
filters at our institution.
A key observation of the present study is the apparent
loosening of the indications for filter placement. Prophy-
lactic IVC filter placement increased from 2.6% to 7.9% of
total filter placements over the past decade indicating per-
haps an increased recognition of the potential morbidity of
VTE and a reduced procedural morbidity. Increased utili-
zation by trauma surgeons in patients known to be at high
risk represents the greatest number and percent increase of
prophylactic filters. Combined absolute and relative indica-
tions were overwhelmingly ( 90%) the indication for filter
placement in both time periods and among all provider
groups. However, placement for absolute indications de-
creased from 67% to 57% while placement for relative
indications increased from 25% to 35% (P .061), perhaps
also reflecting the perception of decreased morbidity and
ease of placement with the newer low-profile filter designs.
Another key observation in the present study is the
marked increase in placement for calf vein (infrapopliteal)
DVT from 2.6% in 1995 to 8.5% in 2005. While not
statistically significant, this represents a clear and disturbing
trend toward loosening in the indications for IVC filter
placement. Follow-up duplex imaging in patients in the
infrapopliteal DVT group with worsening clinical symp-
toms following filter insertion (28%, 10/36) documented
progression in 90% of these patients (9/10); raising a
significant concern for inappropriate and excessive use of
filters in this subgroup. Follow-up duplex imaging in pa-
tients in the infrapopliteal DVT group with worsening
clinical symptoms following filter insertion (28%, 10/36)
documented progression in 60% (6/10) of these patients,
raising a significant concern for inappropriate and excessive
use of filters in this subgroup. Of those patients receiving an
IVC filter for infrapopliteal DVT (n  40), the vast major-ity were not being treated with any anticoagulation (88%).
None of the IVC filters placed for infrapopliteal DVT in
patients that were not being treated with anticoagulation
were placed by vascular surgeons. Moreover, none of the
patients receiving IVC filters for infrapopliteal DVT who
had documented progression (n  6) were being treated
with anticoagulants. This suggests a possible misunder-
standing on the part of the treating physician with respect
to both the indications for IVC filter placement and the
natural history of venous thromboembolic disease. Thus,
the results of the present study suggest that increased
facility of percutaneous placement has increasingly re-
moved the vascular surgeon from the decision-making pro-
cess for filter placement as demonstrated both by changes in
providers and increased placement for relative indications
and prophylaxis. Further studies to document the impact of
this trend in safety and cost-effectiveness appear to be
clearly indicated.
In summary, a number of factors appear to be driving
increased placement of IVC filters at our large tertiary care
institution: increased recognition and awareness of the
consequences of venous thromboembolic disease, increases
in the number of trauma patients and patients having high
risk orthopedic procedures, increased availability and reli-
ability of noninvasive venous duplex scans, changes in the
numbers of providers qualified to place IVC filters, changes
in filter design and technology allowing percutaneous
placement, and finally, a shift from absolute to relative and
prophylactic indications for IVC filter placement. The latter
three factors deserve further study to assess in an objective,
quantifiable fashion the long-term morbidity related to
filter placement and further longitudinal follow-up is
needed to assess outcomes in patients receiving filters for
relative indications.
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Underlying disease* No of events (%) 1995
Diseases of respiratory system 28 (37%)
Diseases of cardiovascular system 55 (72%)
Diseases of central nervous
system
19 (25%)
Diseases of musculo-skeletal
system
19 (25%)
Diseases of skin 13 (17%)
Diseases of endocrine system 21 (28%)
Diseases of blood 20 (26%)
Diseases of digestive system 27 (36%)
Neoplastic disorder 23 (30%)
Diseases of genito-urinary system 45 (59%)
Infectious disorder 44 (58%)
Injury 9 (12%)
Complication of pregnancy 1 (1.3%)
*Underlying disease at the time of Inferior vena cava (IVC) filter placement b
placement.N  76 No of events (%) 2005 N  470 P value
238 (51%) .026
359 (76%) .45
174 (37%) .042
190 (40%) .010
94 (20%) .56
166 (35%) .19
221 (47%) .0007
236 (50%) .017
150 (32%) .77
253 (54%) .38
232 (49%) .17
61 (13%) .78
0 (0%) .14
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 1 Yunus et al 165.e2Table III. online only. Number of IVC filters placed for each indication
Filters placed for absolute indications 1995 N  51/76 (67%) 2005 N  267/470 (57%) P value .09
Bleeding complication 30 (58.8%) 170 (63.7%) .51
CNS infarct/tumor/trauma surgery 2 (3.9%) 36 (13.5%) .05
Thrombocytopenia 2 (3.9%) 8 (3.0%) .67
Trauma – solid organ injury 0 (0%) 5 (1.9%) 1.00
Recurrent PE with anticoagulation 16 (31.4%) 40 (15.0%) .0049
Progression of DVT with
anticoagulation
0 (0%) 5 (1.9%) 1.00
Heparin associated
thrombocytopenia
1 (2.0%) 3 (1.1%) .50
Filters placed for relative indications 1995 N  23/76 (30%) 2005 N  166/470 (35%) P value .39
Poor candidate – old age/ falls 4 (17.4%) 91 (54.8%) .0008
Poor compliance 1 (4.4%) 13 (7.8%) 1.00
Neoplasm with potential to bleed 3 (13.0%) 12 (7.2%) .40
Periprocedural period 11 (47.8%) 29 (17.5%) .0021
Massive PE 3 (13.0%) 14 (8.4%) .44
Free-floating ileo femoral DVT tip 1 (4.4%) 6 (3.6%) 1.00
During/after surgical embolectomy 0 (0%) 1 (0.6%) 1.00
Filters placed for prophylactic
indications 1995 N  2/76 (2.6%) 2005 N  37/470 (7.9%) P value .10
Long bone/pelvic fractures 2 (100%) 9 (24.3%) .07
Spinal cord injury 0 (0%) 9 (24.3%) 1.00
Morbidly obese/immobile patient 0 (0%) 6 (16.2%) 1.00
Prior to spine surgery 0 (0%) 1 (2.7%) 1.00
Prior to bariatric surgery 0 (0%) 12 (32.4%) 1.00IVC, Inferior vena cava; CNS, central nervous system; PE, pulmonary embolism; DVT, deep venous thrombosis.Table IV. online only. Providers for IVC filters placed with relative indications
Filters placed by cardiologists for relative indications 1995 N  12/38 (32%) 2005 N  63/135 (47%) P value .10
Poor candidate – old age/falls 4 (33%) 35 (56%) .16
Poor compliance 1 (8.3%) 5 (7.9%) 1.00
Neoplasm with potential to bleed 1 (8.3%) 7 (11.1%) 1.00
Periprocedural period 4 (33%) 11 (17.5%) .24
Massive PE 1 (8.3%) 4 (6.4%) 1.00
Free-floating ileo femoral DVT tip 1 (8.3%) 1 (1.6%) .30
During/after surgical embolectomy 0 (0%) 0 (0%) ***
Filters placed by radiologists for relative indications 1995 N  11/38 (29%) 2005 N  78/223 (35%) P value .47
Poor candidate – old age/falls 0 (0%) 46 (59%) .0002
Poor compliance 0 (0%) 8 (10%) .59
Neoplasm with potential to bleed 2 (18%) 5 (6.4%) .21
Periprocedural period 7 (64%) 8 (10%) .0002
Massive PE 2 (18%) 7 (9%) .31
Free-floating ileo femoral DVT tip 0 (0%) 3 (3.9%) 1.00
During/after surgical embolectomy 0 (0%) 1 (1.3%) 1.00
Filters placed by surgeons in 2005 for relative indications Trauma surgeons N  9 Vascular surgeons N 16
Poor candidate – old age/falls 1 (11%) 9 (56%)
Poor compliance 0 (0%) 0 (0%)
Neoplasm with potential to bleed 0 (0%) 0 (0%)
Periprocedural period 4 (44%) 6 (37.5%)
Massive PE 2 (22%) 1 (6.3%)
Free-floating ileo femoral DVT tip 2 (22%) 0 (0%)
During/after surgical embolectomy 0 (0%) 0 (0%)IVC, Inferior vena cava; PE, pulmonary embolism; DVT, deep venous thrombosis.
JOURNAL OF VASCULAR SURGERY
January 2008165.e3 Yunus et alTable V. online only. Provider and indications for IVC filter placement in patients with infrapopliteal DVT only
Indication for placement Cardiologist Radiologist Vascular surgeon Trauma surgeon
Absolute – bleeding complication 7 (38.9%) 8 (38.1%) 0 0
Absolute – CNS infarct/tumor/trauma surgery 1 (5.6%) 3 (14.3%) 0 0
Absolute – recurrent PE with anti-coagulation 0 1 (4.8%) 0 0
Absolute – heparin associated thrombocytopenia 1 (5.6%) 1 (4.8%) 0 0
Relative – poor candidate old age/falls 6 (33.3%) 6 (28.6%) 1 0
Relative – neoplasm with potential to bleed 2 (11.1%) 0 0 0
Relative – periprocedural period 1 (5.6%) 2 (9.5%) 0 0
Total  40 in 2005 18 21 1 0IVC, Inferior vena cava; CNS, central nervous system; PE, pulmonary embolism; DVT, deep venous thrombosis.
The two filters placed in 1995 for this patient group were for absolute indications and inserted by radiologists. This table is for 2005 year patients.
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breakdown by indication subtype
Filters placed for
absolute Indications N
Post-filter
anticoagulation
Follow-up duplex ultrasound Follow-up chest CT
No
Yes – no
progression
Yes – clot
progression No
Yes – no
new PE
Yes – new
PE
Bleeding complication 170 13 (7.7%) 122 (72%) 20 (12%) 28 (16%) 148 (87%) 19 (11%) 3 (1.7%)
CNS infarct/tumor/
trauma surgery
36 5 (13.9%) 26 (72%) 1 (2.8%) 9 (25%) 33 (92%) 2 (5.6%) 1 (2.8%)
Thrombocytopenia 8 3 (37.5%) 5 (63%) 2 (25%) 1 (13%) 8 (100%) 0 0
Trauma – solid organ
injury
5 2 (40%) 3 (60%) 1 (20%) 1 (20%) 6 (100%) 0 0
Recurrent PE with
anticoagulation
40 23 (57.5%) 24 (60%) 11 (28%) 59 (12%) 29 (73%) 10 (25%) 1 (2.5%)
Progression of DVT
with
anticoagulation
5 2 (40%) 4 (80%) 0 1 (20%) 5 (100%) 0 0
Heparin associated
thrombocytopenia
3 1 (33%) 3 (100%) 0 0 3 (100%) 0 0
Totals 267 49 (18%) 187 (70%) 35 (13%) 45 (17%) 231 (87%) 31 (12%) 5 (1.9%)
Filters placed for
relative indications N
Post-filter
anticoagulation
Follow-up duplex ultrasound Follow-up chest CT
No
Yes – no
progression
Yes – clot
progression No
Yes – no
new PE
Yes – new
PE
Poor candidate – old
age/ falls
91 14 (15%) 75 (82%) 11 (12%) 5 (5.5%) 87 (96%) 4 (4%) 0
Poor compliance 13 5 (38%) 8 (62%) 2 (15%) 3 (23%) 8 (62%) 3 (23%) 2 (15%)
Neoplasm with
potential to bleed
12 5 (42%) 7 (58%) 2 (17%) 3 (25%) 11 (92%) 1 (8.3%) 0
Periprocedural period 29 17 (59%) 18 (62%) 7 (24%) 4 (14%) 27 (93%) 2 (6.8%) 0
Massive PE 14 12 (86%) 8 (57%) 4 (29%) 2 (14%) 10 (71%) 4 (29%) 0
Free-floating ileo
femoral DVT tip
6 4 (67%) 4 (67%) 2 (33%) 0 5 (83%) 1 (17%) 0
During/ after
embolectomy
1 1 (100%) 1 (100%) 0 0 1 (100%) 0 0
Totals 166 58 (35%) 121 (73%) 28 (17%) 17 (10%) 149 (90%) 15 (9%) 2 (1.2%)
Filters placed for
prophylactic
indications N
Post-filter
anticoagulation
Follow-up duplex ultrasound Follow-up chest CT
No
Yes – no
progression
Yes– clot
progression No
Yes – no
new PE
Yes – new
PE
Long bone/ pelvic
fractures
9 0 (0%) 7 (78%) 2 (22%) 0 9 (100%) 0 0
Spinal cord injury 9 1 (11%) 7 (78%) 1 (11%) 1 (11%) 7 (78%) 2 (22%) 0
Morbidly obese/
immobile patient
6 0 (0%) 5 (83%) 1 (17%) 0 6 (100%) 0 0
Prior to spine surgery 1 1 (100%) 1 (100%) 0 0 1 (100%) 0 0
Prior to bariatric
surgery
12 0 (0%) 11 (92%) 0 1 (8%) 12 (100%) 0 0
Totals 37 2 (5.4%) 31 (84%) 4 (11%) 2 (5.4%) 35 (95%) 2 (5.4%) 0
Patients with lower
extremity
infrapopliteal DVT
only
40 5 (12.5%) 30 (75%) 4 (10%) 6 (15%) 35 (88%) 5 (12.5%) 0CNS, central nervous system; PE, pulmonary embolism; DVT, deep venous thrombosis; CT, computed tomography.
